NYSE : SI
Shoulder Innovations, Inc. — Key statistics
Healthcare · Medical - Specialties · United States
Last price 20.05 USD (Oct 30, 2026, 11:50 AM EDT) · Market cap 417.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 398.27M |
| Enterprise Value | 314.16M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 20.82M |
| Shares Outstanding | 20.82M |
| Shares Change (YoY) | +21,643.28% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 6.04% |
| Owned by Institutions (%) | 40.73% |
| Float | 10.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.63 |
| Forward PS | 5.14 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 5.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 10.71 |
| Quick Ratio | 8.56 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -40.08% |
| Return on Assets (ROA) | -19.12% |
| Return on Invested Capital (ROIC) | -21.47% |
| Return on Capital Employed (ROCE) | -25.26% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $800,733 |
| Profits Per Employee | -$467,107 |
| Employee Count | 75 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 0.68 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +63.23% |
| 50-Day Moving Average | 19.18 |
| 200-Day Moving Average | 17.01 |
| Relative Strength Index (RSI) | 50.83 |
| Average Volume (20 Days) | 93,734 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.06M |
| Gross Profit | 46.45M |
| Operating Income | -35.15M |
| Pretax Income | -35.03M |
| Net Income | -35.03M |
| EBITDA | -31.32M |
| EBIT | -35.15M |
| Loss Per Share | -$1.85 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 98.99M |
| Total Debt | 14.88M |
| Net Cash | 84.11M |
| Net Cash Per Share | $4.04 |
| Equity (Book Value) | 124.33M |
| Book Value Per Share | 5.97 |
| Working Capital | 124.58M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -37.09M |
| Capital Expenditures | -9.99M |
| Depreciation & Amortization | 3.84M |
| Net Borrowing | 39.86M |
| Free Cash Flow | -47.08M |
| FCF Per Share | -$2.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.34% |
| Operating Margin | -58.53% |
| Pretax Margin | -58.33% |
| Profit Margin | -58.33% |
| EBITDA Margin | -52.14% |
| EBIT Margin | -58.53% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21,643.28% |
| Shareholder Yield | -21,643.28% |
| Earnings Yield | -9.65% |
| FCF Yield | -11.82% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $26.50 |
| Price Target Difference | 38.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 32.79% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.88 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |